Trials / Not Yet Recruiting
Not Yet RecruitingNCT05875649
A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 137 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 14 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Most of patients with acute myeloid leukemia achieved complete remission (CR) after primary induction chemotherapy, there were 20-30% patients without CR after first-induction. It was uncertain how to treat these patients. It was investigated in our study that these patients were re-induced with CLAG Regimen. The CR ratio, overall survival (OS) and relapsed-free survival (RFS) was statistically analysed in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | CLAG | Acute myeloid leukemia patients are re-induced by CLAG Regimen after first-induction failure |
Timeline
- Start date
- 2023-07-02
- Primary completion
- 2027-08-20
- Completion
- 2027-12-20
- First posted
- 2023-05-25
- Last updated
- 2023-07-05
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05875649. Inclusion in this directory is not an endorsement.